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Essentials
 Deficiencies in size, number or shape of platelet gran-
ules are associated with bleeding symptoms.
 Super-resolution microscopy (SRM) facilitates the diag-
nosis of structural platelet disorders.
 SRM can deliver quantitative, automated, unbiased
high-throughput morphometric analyses.
 Using CD63 as a marker, Hermansky-Pudlak patients
are easily distinguished from controls.
Summary. Background: Many platelet functions are
dependent on bioactive molecules released from their
granules. Deficiencies of these granules in number,
shape or content are associated with bleeding. The
small size of these granules is such that imaging them
for diagnosis has traditionally required electron micro-
scopy. However, recently developed super-resolution
microscopes provide sufficient spatial resolution to
effectively image platelet granules. When combined with
automated image analysis, these methods provide a
quantitative, unbiased, rapidly acquired dataset that can
readily and reliably reveal differences in platelet gran-
ules between individuals. Objective: To demonstrate the
ability of structured illumination microscopy (SIM) to
efficiently differentiate between healthy volunteers and
three patients with Hermansky-Pudlak syndrome. Meth-
ods: Blood samples were taken from three patients with
Hermansky-Pudlak syndrome and seven controls.
Patients 1–3 have gene defects in HPS1, HPS6 and
HPS5, respectively; all controls were healthy volunteers.
Platelet-rich plasma was isolated from blood and the
platelets fixed, stained for CD63 and processed for
analysis by immunofluorescence microscopy, using a
custom-built SIM microscope. Results: SIM can success-
fully resolve CD63-positive structures in fixed platelets.
A determination of the number of CD63-positive struc-
tures per platelet allowed us to conclude that each
patient was significantly different from all of the con-
trols with 99% confidence. Conclusions: A super-resolu-
tion imaging approach is effective and rapid in
objectively differentiating between patients with a plate-
let bleeding disorder and healthy volunteers. CD63 is a
useful marker for predicting Hermansky-Pudlak syn-
drome and could be used in the diagnosis of patients
suspected of other platelet granule disorders.
Keywords: diagnostic imaging; Hermansky-Pudlak
syndrome; platelet storage pool disorder; platelets;
super-resolution; structured illumination microscopy.
Introduction
Platelets are cell fragments derived from megakaryocytes.
Their distinguishing features include an open canalicular
system, a dense tubular system (smooth endoplasmic
reticulum) and secretory organelles. Historically, their
granules have been classified into distinct groups based
on their content and appearance by electron microscopy
(EM): dense granules, a granules, multivesicular bodies
and lysosomes [1], plus now also T granules [2]. Most pla-
telet functions are mediated via the release of bioactive
molecules from these organelles. The critical role of plate-
lets in secondary hemostasis is therefore dependent on
their integrity. Deficiencies of these organelles, including
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abnormalities in granule number or size, are associated
with bleeding symptoms [3]. In genetic disorders such as
Hermansky-Pudlak syndrome (HPS) and Chediak-
Higashi syndrome (CHS) the absence of dense granules
significantly slows the rate of effective hemostasis at the
site of an injury [4]. Dense granules (also known as dense
bodies or delta granules) can be visualized using EM and
are recognizable by the presence of a very electron-dense
core (Fig. 1, Figure S1), which is caused by their high cal-
cium content. They also contain serotonin, histamine,
ADP, ATP, GDP, GTP, magnesium pyrophosphate [5]
and polyphosphate [6]. Platelets are thought to each con-
tain three to eight [7] of these organelles.
The established tools available to clinicians for diagnos-
ing dense-granule disorders are currently limited. Discus-
sion within the clinical community suggests that there is
room for additional new techniques, for example as in
recent reports [8,9] suggesting the further use of fluores-
cence-activated cell sorting (FACS)-based assays as a
diagnostic tool in this context. Currently, assays for a
potential dense-granule disorder include aggregation in
response to a panel of agonists, measurement of platelet
nucleotides and/or ATP release and direct counting of
dense granules using EM.
Platelet aggregation is measured by light transmission
aggregometry (LTA) and using platelet agonists, such as
arachidonic acid, thrombin, ADP, epinephrine, collagen
and ristocetin [4], can differentiate between controls and
patients. Despite its widespread use, there are caveats
regarding LTA results: the measurements are not strictly
comparable to physiological platelet aggregation as the
separated platelets in platelet-rich plasma (PRP) only
form aggregates following the addition of soluble agonists
under low shear conditions (stirring). LTA tells us little
about structural malformations. Nucleotide or ATP
release measurements also suffer from the latter defect.
Some structural information about dense granules can
be obtained using a whole-mount EM technique [10,11].
An absence or reduction of dense granules, due to muta-
tions in the cellular machinery used in granule formation,
is found in patients with genetic disorders such as HPS
and CHS [10]. Using whole-mount EM to resolve platelet
granules is currently the reference standard for diagnosing
a dense-granule defect. However, quantitative EM analy-
sis requires an electron microscope and specialized skills,
is time consuming and is very difficult to automate. With-
out markers, granules are difficult to define and identifica-
tion will differ depending on the analyst (12, Figure S1).
Finally, the equipment and specialized techniques
required for both of these analyses are not available in
most hospitals, requiring patients with platelet disorders
to travel long distances to a specialized center.
The limitations of these current techniques suggest an
unmet need for new approaches to diagnosing platelet
granule disorders (PGDs). Until the recent development of
super resolution microscopy (SRM) [13–15], one promising
alternative approach, the acquisition of quantitative data
from immuno-histochemical staining has not been effective
in platelets. Platelets are 2–5 lm in diameter; their dense
granules are approximately 150 nm and their alpha gran-
ules 200–400 nm [16]. While confocal microscopy typically
offers a lateral spatial resolution of 200–300 nm, the new
SRM methods, using a variety of different strategies to
overcome the diffraction limit, can resolve structures in the
10–200 nm range, and thus can easily resolve individual
platelet granules. This improved spatial resolution supports
accurate visualization of distinct objects within a platelet
that are positive for a specific marker. If SRM is coupled
with current automated image analysis methods, quantita-
tive data regarding the platelet granules can be extracted.
Here we provide a proof-of-principle dataset showing
the ability of one SRM approach, structured illumination
microscopy (SIM [17]), to discriminate between a group of
healthy controls and three patients with platelet storage
disorders. In this limited analysis, the dense-granule abnor-
malities caused by HPS were investigated using CD63 as a
marker. This particular marker was used because of reports
of changes to CD63 in HPS patients [18]. Our results sug-
gest that this general approach could be a valuable addi-
tion to the diagnosis of patients with platelet storage
disorders, not least because it would be widely applicable
once a panel of antibodies that would allow detection of
changes to all the platelet organelles had been validated.
Methods
Patient phenotyping
The three patients with HPS had a similar clinical pheno-
type. All were noted to have oculocutaneous albinism
from birth and a history of excessive bleeding after
trauma. Patient 1 has pulmonary fibrosis but patients 2
and 3 do not. Platelet function assays showed similar
results in all three cases with reduced LTA to a standard
panel of agonists and very low levels of platelet ADP
documented by bioluminescent assay of the nucleotide
content in lysed platelets. Genetic analysis was performed
by exome sequencing on the ThromboGenomics platform
that includes HPS1-9.
Patient 1 had compound heterozygosity for two single
nucleotide deletions resulting in frameshifts and introduc-
ing premature stop codons in the HPS1 gene: c.418delG
and c.1189delC predicted to result in p.A140Rfs*34 and
p.Q397Sfs*1. Patient 2 had compound heterozygosity for
two single nucleotide duplications resulting in frameshifts
and introducing premature stop codons in the HPS6
gene: c.902dupC and c.1083dupC predicted to result in
p.T303Hfs*64 and p.G362Rfs*5. Patient 3 had homozy-
gosity for a single nucleotide change introducing prema-
ture stop codons in the HPS5 gene: c.2232T>A predicted
to result in p.Cys744*. Controls were healthy volunteers.
This work was approved by the relevant UK research
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ethics committee and all participants gave their written
informed consent.
Preparing platelets for analysis
First 7 ml of whole blood was collected into a 1 : 7 solution
of acid citrate dextrose (ACD) and centrifuged at 180 9 g
for 17 min. PRP was collected from the supernatant and
left for 30 min, then diluted 1 : 10, 1 : 50, 1 : 100 and
1 : 500 in HEPES Tyrode’s buffer and fixed with formalde-
hyde in phosphate buffered saline (PBS) at a final concen-
tration of 4% for a minimum of 10 min before
centrifugation at 600 9 g for 5 min in a Beckman–Coulter
Allegra 6R onto poly-L-lysine-coated coverslips and
washed once with PBS. Permeabilization with 0.2% TX-100
in PBS was followed by incubation with primary (antitubu-
lin antibody from Cytoskeleton Inc., (Denver, CO, USA)
catalogue number ATN02, used at a concentration of
1 : 200; anti-CD63 antibody from Abcam (Cambridge,
UK), catalogue number AB59479, used at a concentration
of 1 : 100) then secondary antibodies (concentration
1 : 500) conjugated to Alexa Fluor dyes (Molecular Probes,
Life Technologies, Paisley, UK) or Cy5 (Jackson Immu-
noResearch Laboratories, West Grove, PA, USA) before
mounting (ProLong Gold antifade reagent, Life Technolo-
gies). Imaging was carried out using an inverted wide-field
fluorescence microscope (IX71, Olympus, Tokyo, Japan)
modified for SIM, as previously described [19,20].
Once the blood was taken, the samples were fixed and
stored at 4 °C for up to a month or imaged directly. We
found no difference in the quality of images relating to the
length of time between collection and imaging (data not
shown), strongly suggesting that distant collection and fixa-
tion of samples for centralized processing should be possible.
Super-resolution microscopy of platelets
Each SRM image was reconstructed from a sequence of
raw images of the sample acquired under excitation with
nine different sinusoidal illumination patterns, as previ-
ously described [12], with a typical exposure time of
200 ms. For comparison, diffraction-limited images were
created by summing all nine raw images. out-of-focus
light in each image was suppressed by using linear weight-
ing of Fourier space image information components, as
described previously [19,20]. Two-color images were
acquired sequentially under excitation of the sample with
laser light at 488 nm (CD63) and 561 nm (tubulin).
Image z-stacks were obtained by axially translating the
specimen in 0.2-lm steps using a piezoelectric translation
stage (NanoScanZ, Prior Scientific, Cambridge, UK).
Automated image analysis workflow
An automated workflow written as an ImageJ macro was
used to segment SIM images of CD63 granules and assign
granules to their constituent platelets (Fig. 2). Platelets
were segmented using the addition of the tubulin image
to its corresponding CD63 image. Uneven background
illumination was removed from this composite image
using a rolling ball background subtraction with a radius
of 20 pixels [21]. Image noise was reduced with Gaussian
blurring, with a sigma value not impacting the image res-
olution, and finally a minimum error threshold was
applied [22]. The segmented tubulin-labeled structures in
the binary image were filled and a watershed transform
performed to separate touching platelets. To demarcate
the interior of the platelet, the filled area was eroded to
avoid any contribution of CD63 found at the platelet sur-
face. Segmented structures with an area of less than
2.0 lm2 (the reported diameter of platelets varies from 2
to 5 lm and in this set of individuals our tubulin ring
measurements gave areas ranging from 2.3 to 3.1 lm2) or
circularity (defined as 4p(area/perimeter2) less than 0.7)
were removed [23]; for the remaining foreground objects,
morphometric measurements were taken.
Segmentation of CD63-positive structures for each of
the seven control CD63 image datasets was performed
according to a threshold value obtained from moment
preserving thresholding [24]. The three patient data
threshold values were set according to control data that
were acquired on the same day. Segmented CD63 gran-
ules that were overlapping were separated with a water-
shed transform and areas smaller than 0.01 lm2 were
considered background and removed (average diameter of
dense granules 150 nm, area ≥ 0.018 nm2). The platelet in
which each CD63 granule was located was saved and
morphometric features (including area) were measured.
CD63 distribution measurements
From a total population of 2812, platelets were selected
with a more stringent circularity criterion of > 0.85, giv-
ing a reduced sample of the 1549 most circular platelets.
To assess the spatial distribution of CD63 within each
platelet, the radial distribution of pixel values in both the
CD63 and tubulin channels was computed using the
radial profile plugin in ImageJ [25]. The plugin creates a
set of concentric rings from the center of each platelet to
the edge and in each ring calculates the normalized inte-
grated density, which is the sum of pixel values in that
ring divided by the number of pixels in the ring. The edge
of the platelet is defined as the radial distance to the ring
with maximum normalized integrated density in the tubu-
lin channel. The radial distance is normalized for each
platelet by division of the radial distance from the center
for each ring by the distance to the edge ring. Similarly,
radial integrated density is normalized by dividing the
integrated density for each ring by the maximum inte-
grated density value for that platelet. Normalization of
both the radial distance and radial integrated density
allows platelet distributions to be compared indepen-
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dently of the size of the platelet and the pixel intensities.
In order to compare spatial distributions across different
segmented platelets, CD63 channel pixel values were nor-
malized by the total integrated signal and the radial dis-
tance from the platelet center was normalized to the
maximum radius of the tubulin ring.
Whole-mount electron microscopy
PRP was diluted in HEPES Tyrode’s buffer and cen-
trifuged at 600 9 g for 5 min in a Beckman Coulter
Allegra 6R onto formvar-coated mesh copper grids.
The grids were washed twice in water, dried for 20 min
and imaged directly by TEM without fixation (Tecnai
Spirit, FEI, Hillsboro, OR, USA). Images of whole-
mount platelets were randomized and counted by one
analyst (Fig. 1). All images were counted in one sitting
to avoid variation in counting criteria. For this many
samples, it took a relatively experienced cell biologist
accustomed to examining all kinds of images around
6 h to count all the dense granules from 1008 platelets
for this dataset. Images too ambiguous to count were
discarded. An example of which objects were classified
as dense granules is provided in Figure S1.
Results
For this study, we chose to use SIM for its simplicity of
sample preparation, compatibility with routinely used flu-
orescent labels and fast image-acquisition rates. Platelet
samples prepared by a simple robust protocol (Methods)
were imaged on a custom-built SIM and, in parallel, by
whole-mount EM to provide a reference-standard diag-
nostic image-set for comparison.
Fixed platelets were centrifuged onto poly-L-lysine cov-
erslips to create a high density of platelets to analyze,
because this dramatically reduces imaging time. To deter-
mine the number of CD63-positive structures per platelet,
we co-stained for tubulin to demarcate the perimeter of
individual platelets, within which segmented granules
were counted (Fig. 2). This allowed an analysis based on
granules per platelet, thus giving a more sensitive readout.
The improved spatial resolution and removal of out-of-
focus background obtained by SIM is clearly apparent
when compared with wide-field microscopy (Fig. 3A, B).
The improved images obtained with SIM greatly facili-
tated the identification and counting of CD63-positive
structures (Figs. 3B and 2).
Samples of platelets taken from three patients with
HPS and from seven healthy volunteers were used to test
the ability of SIM (Figs. 3 and 4) to differentiate between
the groups. To compare with the current reference-stan-
dard technique, we performed a whole-mount EM analy-
sis (Figs. 1 and 5). Due to the stringent criteria
established (Figure S1) and the use of only one analyst to
blindly count all 1008 platelets, a significant difference
(99% confidence) was observed as very few of the patient
platelets had any dense granules at all (Fig. 5); the mean
number of dense granules in the controls was 3.5 (stan-
dard deviation, 1.2), compared with 0.07 for the patients
(standard deviation, 0.02). An empirical cumulative distri-
bution function (ECDF) plot (Fig. 5A) demonstrates the
clear distinction between the control and HPS patient
populations. As a non-parametric test was required to
analyze significance (due to the Poisson-like distribution
of the dense granule counts), a Kruskal–Wallis test was
used to compare the results (Fig. 5B) and a significant
difference was seen between the controls and the patient
groups (99% confidence) and between each of the
patients and all of the controls, using a multiple compar-
ison test (99% confidence). Equivalent results were
obtained using ANOVA (not shown).
Having established that our three HPS patients do
indeed lack dense granules, as seen by EM, we tested the
same blood samples by SRM, labeling for CD63 and
tubulin and counting the number of CD63-positive struc-
tures by SIM, using an automatic workflow that relied on
no user-defined settings and is thus entirely unbiased. We
found that the mean number of CD63-positive structures
per platelet determined by SIM was 6.8 (standard devia-
A B C D
Fig. 1. Whole mount EM of Platelets. Analysis of dense granules by whole mount EM may be regarded as the “gold standard” for determining
numbers of these organelles per platelet. Examples of single platelets from one of the 7 healthy volunteers (A) and from each HPS Patient 1, 2
and 3 (B,C,D) used in this study are shown. Note the lack of dense granules (black spots) seen in the HPS patients. The criteria for counting
dense granules are described in Supplementary Figure 1. Scale bars: 1 lm.
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tion, 0.45) for controls, whereas for patients it was 2.4
(standard deviation, 0.48). The mean number of CD63-
positive structures for controls is about twice as many as
for dense granules, as counted by EM: 3.5 as opposed to
6.8. This must reflect the presence of CD63 on other
organelles within the platelets, as expected for such an
itinerant membrane protein. However, despite this differ-
ence in baseline, the important finding is that (either by
EM or SRM) a highly significant difference between con-
trols and patients is seen and therefore SRM could act as
an effective determinant of a dense-granule disorder.
As a non-parametric test was required to analyze signif-
icance (due to a Poisson-like distribution of the CD63
data), a Kruskal–Wallis test was used to compare the
results (Fig. 6B) and a significant difference was seen
between the controls and the patient groups (99% confi-
dence) and between each of the patients and all of the
controls, using a multiple comparison test (99% confi-
dence). An ECDF plot (Fig. 6A) demonstrates the clear
distinction between control and HPS patient populations.
In order to further simplify the ECDF readout, a thresh-
old of four or more CD63-positive structures per platelet
was chosen and the proportion of platelets above this
threshold was plotted (Fig. 6C); this clearly demonstrates
the differences between controls and patients in the study
and could be used as a quick read-out to highlight a
potential PGD.
Another potential advantage of a microscopic approach
is that a single image can provide data on more than one
parameter, even when a single antibody is used to track
one protein. One aspect of CD63 behavior in cells defec-
tive in the formation of lysosome-related secretory orga-
nelles such as platelet granules, is that defects in the
targeting of proteins to those granules can lead to an
abnormal accumulation on the cell surface. This has pre-
viously been reported for cells from BLOC-1-deficient
HPS and AP-3-deficient HPS 2 patients and their corre-
sponding mouse models [26,27]. We therefore analyzed
surface CD63 for these same SIM images. Using the
tubulin ring as a guide for the edge of the platelets, where
by definition the plasma membrane is located, we mea-
sured levels of plasma membrane-localized CD63 in con-
trols and patients. Quantitation (Fig. 7) shows a highly
significant increase in plasma membrane-localized CD63
in HPS patients, in line with those previous results. This
preliminary finding strengthens our overall conclusions
and shows how a simple sample preparation imaged by
SRM can provide two independent fully quantitative
measures of this particular disease.
Discussion
The current methods for testing for a PGD typically
include LTA and measurement of platelet nucleotides [4].
To characterize the platelet granules, we used SRM to
analyze the distribution of CD63, an itinerant integral
membrane protein that traffics between post-Golgi orga-
nelles and has been found to be present on many secre-
tory granules, endosomes and lysosomes, as well as
lysosome-related organelles [28]. Importantly, CD63 has
been shown to be present in dense granules and to have
an altered distribution in HPS patients [18,29]. Our data
suggest that an SRM approach coupled with morphomet-
ric analyses could be an effective and rapid approach to
differentiating between a patient with a platelet bleeding
disorder and healthy volunteers.
The sensitivity of our analysis by SIM is demonstrated
by the ability of this technique to distinguish between three
HPS patients and seven controls (99% confidence), not
only regarding the number of CD63-positive structures but
also the distribution of CD63 within their platelets. Indeed,
we estimate, using a one-sample t-test for the two popula-
tions (patients vs. controls), that a sample size of 25 plate-
lets would have been sufficient to give a similar probability
of detection of HPS. However, because HPS causes an
almost complete loss of dense granules, this is a relatively
easy syndrome to diagnose. In this study, we analyzed an
average of 281 platelets per person, because this greater
A B C D
Fig. 2. Structured illumination microscopy (SIM) segmentation workflow. SIM images were analyzed as follows: platelets were segmented using
the image of the tubulin and corresponding CD63 image (A) and then filled (B). Platelets were distinguished from debris by their area and cir-
cularity. Granules within the filled area (B) were segmented according to a threshold value obtained from ‘Moment-preserving thresholding’
(C). The platelet in which each CD63 granule is located was recorded (D) and morphometric features (including area) of each granule were
measured. Scale bars: 1 lm.
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number does not affect the time, cost or sample size
required, yet would potentially increase the sensitivity of
analysis to allow detection of a much less severe phenotype.
It would be easy to analyze much larger numbers of plate-
lets if this was required to further increase sensitivity.
SIM is able to resolve CD63-positive structures and is
the only technique currently reported that could poten-
tially report morphological data from a number of alpha
and dense-granule markers at the same time, detailing
quantitative information as to the distribution and aber-
rant localization of markers, all in one sample, which can
be fixed and analyzed in parallel in large numbers.
Because conventional microscopy does not allow the
resolution afforded by instruments that are not diffrac-
tion limited, SIM is becoming a more common technique
(publications show an exponential rise since 2005). It is
also less expensive to maintain and less labor intensive
than an EM. Further, the small number of operations
carried out on the platelets will improve simplicity and
thus increase reliability.
Among the currently available SRM methods, SIM is
the simplest to use, as samples can be easily fixed and
imaged and the time-consuming steps needed to ensure
the improvement in resolution of STORM (Stochastic
Optical Reconstruction Microscopy) or STED (Stimu-
lated Emission Depletion) are unnecessary. Previous mor-
phological dense-granule analyses have relied upon
manual counting of granules in a whole-mount image
[18], whereas the counting of CD63-positive structures on
2812 platelets (in total) by SIM was achieved in our study
in less than 5% of the time needed for the manual analy-
sis of 1008 platelets (in total) by EM, yet gave the same
result. Additionally, centrifugation of fixed platelets onto
poly-lysine-coated coverslips reduces the amount of blood
required to produce 96 coverslips of platelets to less than
1 ml, and this could potentially even be scaled down to a
pinprick sample. Fixed platelets are also stable for several
months at 4 °C and could be sent to a central facility for
diagnosis by SIM and imaged/re-analyzed at a later date
if required, relieving local laboratories of the burden of
equipment acquisition and training. Recently published
FACs methods for diagnosing PGDs [8,9] do demonstrate
additional ways to carry out functional tests of platelets,
but as with all functional assays, this can only be carried
out immediately on site after the collection of samples,
and would not detect defects in protein localization.
One other potential method that could be used to
analyze dense granules would be vital staining with
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Fig. 3. Imaging platelets by SIM. (A) Platelets (prepared as in Methods) were imaged by SIM (lower right) with a diffraction-limited widefield
microscopy image (upper left) shown for comparison. The images show the platelet perimeter (marginal band) labelled (red) with anti-tubulin
(Cytoskeleton Inc., sheep polyclonal ATNO2) and the internal structures (green), largely dense granules, labelled with anti-CD63 (Abcam,
mouse monoclonal AB59479). (B) The improved contrast and resolution in the SIM image (right) is clearly apparent from a 600 nm line profile
(lower panel) taken through two closely adjacent structures. This improvement in image quality facilitates granule separation, allowing for an
efficient, high throughput, automated, unbiased workflow. Scale bar: 1 lm.
Fig. 4. Structured illumination microscopy (SIM) of platelets. Example SIM images of platelets from one of the seven healthy volunteers (A)
and from each Hermansky-Pudlak syndrome (HPS) patient (1, 2 and 3) (B, C, D) used in this study. The images in the first column are an
example of the SIM data as analyzed (Fig. 6); images in the second and third columns have been similarly contrast enhanced, with a magnified
portion of those images shown in column 3. The two-color images were acquired sequentially under excitation of the sample with laser light at
488 nm (CD63) and 561 nm (tubulin); z-stacks are displayed as maximum intensity projections. Scale bars: 4 lm for columns 1 and 2; 1.5 lm
for column 3. The data in this figure suggest that platelet size varies between individuals, but does not seem to correlate with this disease. We
do not yet have a database sufficiently large to allow any conclusions to be reached as to significance.
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mepacrine. However, there are drawbacks to using this
technique. Perhaps the most serious issue is that it can
only be used on live platelets, making obtaining the data
more difficult, and importantly precludes a real reduction
in the number of laboratories carrying out the analysis.
Mepacrine also renders the granules sensitive to light, so
that it cannot be used in double- or multiple-labelling
modes in the way that the SIM approach will eventually
be used. Finally, it has been reported that mepacrine
labels both full and empty granules, again potentially
complicating analyses.
Whilst whole-mount EM may clearly distinguish con-
trols from patients with HPS, the technique is difficult
to standardize and is dependent on each sample being
100
A B 1000
800
600
400
200
0
Co
ntr
ol 1
Co
ntr
ol 2
Co
ntr
ol 3
Co
ntr
ol 4
Co
ntr
ol 5
Co
ntr
ol 6
Co
ntr
ol 7
Pa
tie
nt 
1
Pa
tie
nt 
2
Pa
tie
nt 
3
50
%
 c
um
ul
at
ive
 fr
eq
ue
nc
y
M
ea
n 
ra
nk
 o
f d
en
se
 g
ra
nu
le
s 
pe
r p
la
te
le
t
0
0 2
Number of dense granules per platelet
4 6 8
Patients
Controls
Fig. 5. Whole mount EM analysis. Dense granules were manually counted in 1008 platelets from randomised EM images of samples from
seven healthy volunteers and three patients with HPS. A cumulative frequency graph (A) reveals the spread of the data. A Kruskal-Wallis Mul-
tiple Comparison Test (B) was used as the data had a Poisson-like distribution and thus a non-parametric test was needed. The mean rank of
the three HPS patients was significantly different (99% confidence) from all of the controls. Mean rank is a statistic used in the non-parametric
Kruskal-Wallis test to compare observations from different patients.
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Fig. 6. Analysis of structured illumination microscopy (SIM) data. The number of CD63 objects per platelet was counted for 2812 platelets
across seven controls and three patients with Hermansky-Pudlak syndrome (HPS) after segmentation (Fig. 2). A cumulative frequency graph
(A) demonstrates the spread of the data. A Kruskal-Wallis multiple comparison test (B) was used as the data had a Poisson-like distribution
and thus a non-parametric test was needed. The mean rank (a statistic used in the non-parametric Kruskal–Wallis test to compare observations
from different patients) of the three HPS patients was significantly different (99% confidence) from that of all of the controls. An example
readout for clinical use is shown in (C); here the data is displayed as the percentage of platelets containing 4 or more CD63 positive structures.
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processed on the same day and counted by the same
analyst to gain meaningful comparisons. The contrast
within the image is often variable and can lead to diffi-
culties in classifying dense granules. A number of sites
across the North American Specialized Coagulation
Laboratory Association were asked to evaluate the
number of dense granules in one image of one platelet,
and the number of dense granules reported ranged from
six for an inexperienced site to 15–24 for experienced
sites [12]. Added to this is the potential for variation in
sample preparation. For the purpose of our study
extremely stringent criteria were used to analyze the
whole-mount EM images of 1008 platelets; the same
analyst counted all images blind and on the same day.
Although the result is striking (Fig. 5), the time-con-
suming nature and subjective criteria required to imple-
ment this technique make it non-ideal for clinical use.
This highlights an important advantage of the SIM
analysis presented here, where there is no user-defined
threshold applied to the segmentation and counting of
granules. An automatic thresholding value set by
‘Moments’ in ImageJ [24] selects the parameters auto-
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Fig. 7. CD63 at the platelet surface in Hermansky-Pudlak syndrome (HPS) platelets. A representative platelet is shown from the controls (A)
and each of the HPS patients (B, C, D). The images show the platelet perimeter (marginal band) labelled (red) with anti-tubulin in column 1
and the structures labelled with anti-CD63 (green) in column 2. To highlight the change in distribution of CD63, only the green channel was
contrast enhanced. Column 3 shows the merge of the green and red channels. Unlike the control (A), the three HPS patients (B, C, D) have an
accumulation of CD63 at the platelet surface. To quantify this surface accumulation a radial profile algorithm was used. This calculates the
normalized integrated intensity in a set of concentric rings, from the center of each platelet (0 on the x axis in E, F) to the platelet radius (1 on
the x axis in E, F). The platelet radius is defined as the distance from the center of the platelet to the outer ring, where the outer ring is the
maximum integrated intensity ring in the tubulin channel. The integrated intensity values are normalized for each concentric ring by division of
the maximum integrated intensity ring of the platelet. Similarly, for each platelet, radial distances are normalized by division of the platelet
radius. Normalization of both the radial distance and radial integrated intensity allows platelet distributions to be compared independently of
the size of the platelet and the pixel intensities. A generalized additive model (GAM) was used for smoothing. As shown in E and F, only the
HPS patients have an increase in signal towards the platelet surface (1 on the x axis in E, F). F represents the mean values of the individual
controls and patients from E. Scale bars: 1 lm.
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matically and thus results could be easily compared
between different analysts without any subjective analy-
sis. SIM-based methodology could easily be applied to
a high-throughput microscopy platform with automated
data analysis that would present the results to a clini-
cian for interpretation.
Current LTA methods are not specific for dense-gran-
ule disorders and provide no information about platelet
structure. A whole-mount EM approach to analyze pla-
telets is also limited to the visualization of dense gran-
ules and thus alpha granule disorders, such as Gray
platelet syndrome, cannot be identified by this method;
transmission EM of thin sections of fixed embedded
platelets [30] can be used to visualize alpha granules
but sample preparation to achieve this is even more
time consuming and requires highly skilled technicians,
and is therefore not practical to routinely implement in
a clinical context.
For routine diagnostic purposes it could be argued that
it is counter-productive to categorize granules as alpha
and dense granules, as there is no efficient technique to
analyze both within a large number of platelets. Alpha
and dense granules are distinct but many markers that
are claimed to label alpha granules and dense granules do
not share the same structures when analyzed by
immunofluorescence. For example, Kamykowski et al.
report that 15 different markers for alpha granules fail to
show any significant co-clustering [31]. Whether a large
super-resolution morphometric dataset collected over time
from many patients would reveal marker clustering asso-
ciated with different diseases will therefore be of signifi-
cant interest.
In 2013 it was reported that 76% of patients with HPS
were initially misdiagnosed and 28% of patients had to
see four to six specialists before receiving the correct diag-
nosis [32]. Thus improvements to speed, accuracy and
sensitivity would be welcome.
The procedure presented here provides a quantitative
automated unbiased methodology, which can be further
extended by the addition of other marker-specific
immunoprobes to simultaneously quantify other platelet
structures such as a-granules, and can also measure
parameters such as the size and shape of organelles, and
novel parameters that arise, such as the fraction of any
membrane protein on the platelet surface, can also be
extracted from the morphometric datasets to provide
other or compound diagnostics. Finally, analysts would
also be able to mine an increasing collection of standard-
ized morphometric data to reveal new disease phenotypes,
as well as combinations of markers that would improve
future diagnosis.
Addendum
D. Westmoreland, M. Shaw, D. J. Metcalf, A. E. Knight,
J. J. Burden and W. Grimes performed experiments. D.
F. Cutler, A. E. Knight and K. Gomez designed the
research. All authors analyzed data, and wrote and edited
the manuscript.
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Fig. S1. Whole-mount electron microscopy (EM) count-
ing criteria. Whole-mount EM of a control platelet
demonstrating the counting criteria employed in this
study. Only dense structures that were of a certain con-
trast with a defined structure and size were counted
(black arrows). All counting was performed without
knowledge of the origin of the platelet, in a full set of
randomized images; stringent criteria were chosen, as
there are many structures that resemble dense granules
(white arrows) that were not counted but could affect the
reliability of the results if included. Scale bars: 1 lm
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